CytomX Therapeutics Inc. (CTMX) Climbed 12.69% or 2.8 To Price $24.86 On Wednesday


CytomX Therapeutics Inc. (CTMX) climbed 12.69% or 2.8 to $24.86. It is approximately 561371 shares traded, which is 145.36% compare to the average total volume 386198. The market cap of CTMX is $968.48 million. The year to date change is 1270.68%. The 52 week price range is from $13.0 to $35.0. Price of CTMX have changed -13.86% during last week. It have changed -10.65% over last month, -32.46% over last 3 months, 7.35% over last 6 months and 58.36% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 26.29. It is 5.75% above current price. The 200-day Moving Averages for CTMX is 23.69. It is -4.71% below current price. The 52-week High is 35.0. It is 40.79% from the current price. The 52-week Low is 13.0. It is -47.71% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 4.22 on 2018-05-15. Short % to float is 3.58%. There are some statistics of CTMX. It is has market cap $968.48 million. The share outstanding is 38.96 million. The average volume is 386198. The revenue is 32.90M. The percent of top 15 Institution holding is 67.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -74.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -17.29%.


Tags:

Share this post